FLT4 Antikörper (C-Term)
Kurzübersicht für FLT4 Antikörper (C-Term) (ABIN2385230)
Target
Alle FLT4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1122-1152, C-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- VEGFR-3, CT (Tyrosine-protein kinase receptor FLT4, VEGFR-3)
-
Aufreinigung
- Purified by Protein G affinity chromatography.
-
Immunogen
- VEGFR-3 (FLT4) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1122~1152 amino acids from the C-terminal region of human FLT4.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Andere Bezeichnung
- VEGFR-3
-
UniProt
- P35916
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Target
-